Clinical Trial Update: Evaluation of the IPS System for TLD Therapy in Patients With COPD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the IPS System for targeted lung denervation therapy in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPS System

Snippet

Sponsor: Nuvaira, Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED